8-K: Nuvve Holding Corp. Announces Major Securities Exchange
Securities Exchange and Omnibus Amendment Agreement
Nuvve Holding Corp. has entered into an agreement to exchange existing warrants for common stock and terminate certain financing facilities.
Summary
- Nuvve Holding Corp. entered into a Securities Exchange and Omnibus Amendment Agreement on May 12, 2026.
- The company will exchange existing warrants for an aggregate of 13,107,127 shares of common stock or newly issued pre-funded warrants.
- The agreement terminates the company's existing equity line of credit (ELOC) facility.
- The company will hold a special meeting of stockholders by July 27, 2026, to approve the issuance of shares and amendments to the Series A Preferred Stock.
- The company agreed to file a registration statement for the resale of the exchange shares and pre-funded warrant shares within five days of the agreement.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral-to-cautious development; while it cleans up the capital structure and removes a dilutive ELOC, it highlights ongoing liquidity pressures and the need for shareholder approval to avoid penalties.
Positives
- Termination of the equity line of credit (ELOC) facility reduces potential future dilution from that source.
- Irrevocable waiver and termination of additional investment rights simplifies the company's capital structure.
- The exchange of warrants for common stock or pre-funded warrants provides clarity on the company's outstanding equity obligations.
Negatives
- The company faces potential liquidated damages of 1.5% of the aggregate subscription amount if registration deadlines are not met.
- The agreement requires stockholder approval for the issuance of shares in excess of 19.99% of outstanding common stock, creating execution risk.
- The company is obligated to pay interest at 18% per annum on any unpaid liquidated damages.
Risks
- Failure to obtain stockholder approval by July 27, 2026, will result in the automatic termination of the agreement.
- The company is subject to strict registration deadlines; missing these will trigger significant financial penalties.
- The company's ability to perform its obligations under the agreement is subject to market conditions and potential material adverse effects.
Future Outlook
The company intends to hold a special meeting of stockholders by July 27, 2026, to secure approval for the issuance of shares and amendments to the Series A Preferred Stock, which is a condition for the closing of the exchange.
Management Comments
- The company's board of directors has determined the amendment to the Series A Preferred Stock to be advisable and in the best interest of the company and its stockholders.
Industry Context
StockSavvy.ai notes that this transaction is a common restructuring maneuver for small-cap companies facing liquidity constraints or complex warrant overhangs, aiming to clean up the balance sheet and remove dilutive financing facilities.
Comparison to Industry Standards
- The use of Section 3(a)(9) of the Securities Act for warrant exchanges is a standard practice to avoid registration requirements for the exchange itself.
- The inclusion of liquidated damages for registration delays is a standard investor protection mechanism in private placement transactions.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Amendment to Certificate of Designation | Removal of the Floor Price as a limitation on adjustments to the conversion price of Series A Preferred Stock. | Subject to stockholder approval | Increases potential dilution for common shareholders by allowing lower conversion prices. |
Stakeholder Impact
- Shareholders: Potential dilution from the issuance of 13,107,127 shares and removal of floor price protections.
- Investors: Holders of existing warrants receive common stock or pre-funded warrants and enhanced registration rights.
Next Steps
- File a registration statement within five days of May 12, 2026.
- Hold a special meeting of stockholders on or prior to July 27, 2026.
- Obtain stockholder approval for share issuance and Series A Preferred Stock amendments.
- Close the exchange upon receipt of stockholder approval.
Key Dates
| Date | Description |
|---|---|
| 2024-10-31 | Original issuance date of 2024 Private Placement Warrants and 2024 Additional Investment Rights. |
| 2025-11-14 | Date of 2025 Securities Purchase Agreement. |
| 2025-12-01 | Date of ELOC Agreement. |
| 2025-12-30 | Original issuance date of 2025 Private Placement Warrants and Series A Preferred Stock. |
| 2026-05-12 | Date of Securities Exchange and Omnibus Amendment Agreement. |
| 2026-07-27 | Deadline for Stockholder Approval and special meeting. |
Recommendation
holdThe company is actively restructuring its debt and equity obligations. While this reduces immediate overhang from the ELOC, the potential for further dilution and the reliance on stockholder approval suggest a wait-and-see approach until the restructuring is finalized.
Keywords
Nuvve Holding Corp, Securities Exchange, Warrants, Equity Financing, Corporate Governance, NVVE
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.